Clinical Trial Update: Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study comparing OPTINOSE Sumatriptan with Imitrex (sumatriptan) in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Imitrex (Sumatriptan)
• OPTINOSE Sumatriptan (sumatriptan)

Snippet

Sponsor: Optinose US Inc. | Conditions: Migraine | Phase 1 | Status: COMPLETED